机译:A CONSENSUS ON RISK MITIGATION FOR BROLUCIZUMAB IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Patient Selection, Evaluation, and Treatment
University of Bonn,Univ Bonn;
Dept Ophthalmol,Tokyo Womens Med Univ;
David Geffen Sch Med,Univ Calif Los Angeles;
brolucizumab; intraocular inflammation; retinal vasculitis; retinal vascular occlusion; occlusive retinal vasculitis; adverse events; neovascular age-related macular degeneration; INTRAVITREAL INJECTION; ENDOPHTHALMITIS; RANIBIZUMAB;